Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study

Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same...

Full description

Bibliographic Details
Main Authors: Daniela Lobenwein, Rosalie Huber, Lars Kerbler, Alexandra Gratl, Sabine Wipper, Can Gollmann-Tepeköylü, Johannes Holfeld
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/8/2115
_version_ 1797445716838187008
author Daniela Lobenwein
Rosalie Huber
Lars Kerbler
Alexandra Gratl
Sabine Wipper
Can Gollmann-Tepeköylü
Johannes Holfeld
author_facet Daniela Lobenwein
Rosalie Huber
Lars Kerbler
Alexandra Gratl
Sabine Wipper
Can Gollmann-Tepeköylü
Johannes Holfeld
author_sort Daniela Lobenwein
collection DOAJ
description Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same applies for pre- or postconditioning remains unclear. In a model of cultured SHSY-5Y cells, preconditioning with either poly(I:C), a TLR3 agonist, or SWT was performed before induction of hypoxia, whereas postconditioning treatment was performed after termination of hypoxia. We measured cytokine expression via RT-PCR and utilized Western blot analysis for the analysis of signaling and apoptosis. TLR3 activation via poly(I:C) significantly reduced apoptotic markers in both pre- and postconditioning, the former yielding more favorable results through an additional suppression of TLR4 and its downstream signaling. On the contrary, SWT showed slightly more favorable effects in the setting of postconditioning with significantly reduced markers of apoptosis. Pre- and post-ischemic direct TLR3 activation as well as post-ischemic SWT can decrease apoptosis and proinflammatory cytokine expression significantly in vitro and might therefore pose possible new treatment strategies for ischemic spinal cord injury.
first_indexed 2024-03-09T13:29:51Z
format Article
id doaj.art-11a3f4a2e4e347048ed6a1b95c8f1a0a
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T13:29:51Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-11a3f4a2e4e347048ed6a1b95c8f1a0a2023-11-30T21:19:01ZengMDPI AGJournal of Clinical Medicine2077-03832022-04-01118211510.3390/jcm11082115Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro StudyDaniela Lobenwein0Rosalie Huber1Lars Kerbler2Alexandra Gratl3Sabine Wipper4Can Gollmann-Tepeköylü5Johannes Holfeld6Department of Vascular Surgery, Medical University of Innsbruck, 6020 Innsbruck, AustriaDepartment of Cardiac Surgery, Medical University of Innsbruck, 6020 Innsbruck, AustriaDepartment of Anesthesiology and Intensive Care, Medical University of Innsbruck, 6020 Innsbruck, AustriaDepartment of Vascular Surgery, Medical University of Innsbruck, 6020 Innsbruck, AustriaDepartment of Vascular Surgery, Medical University of Innsbruck, 6020 Innsbruck, AustriaDepartment of Cardiac Surgery, Medical University of Innsbruck, 6020 Innsbruck, AustriaDepartment of Cardiac Surgery, Medical University of Innsbruck, 6020 Innsbruck, AustriaSpinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same applies for pre- or postconditioning remains unclear. In a model of cultured SHSY-5Y cells, preconditioning with either poly(I:C), a TLR3 agonist, or SWT was performed before induction of hypoxia, whereas postconditioning treatment was performed after termination of hypoxia. We measured cytokine expression via RT-PCR and utilized Western blot analysis for the analysis of signaling and apoptosis. TLR3 activation via poly(I:C) significantly reduced apoptotic markers in both pre- and postconditioning, the former yielding more favorable results through an additional suppression of TLR4 and its downstream signaling. On the contrary, SWT showed slightly more favorable effects in the setting of postconditioning with significantly reduced markers of apoptosis. Pre- and post-ischemic direct TLR3 activation as well as post-ischemic SWT can decrease apoptosis and proinflammatory cytokine expression significantly in vitro and might therefore pose possible new treatment strategies for ischemic spinal cord injury.https://www.mdpi.com/2077-0383/11/8/2115thoracoabdominal aneurysmspinal cord ischemiaischemic conditioningToll-like receptor 3shock wave therapy
spellingShingle Daniela Lobenwein
Rosalie Huber
Lars Kerbler
Alexandra Gratl
Sabine Wipper
Can Gollmann-Tepeköylü
Johannes Holfeld
Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
Journal of Clinical Medicine
thoracoabdominal aneurysm
spinal cord ischemia
ischemic conditioning
Toll-like receptor 3
shock wave therapy
title Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_full Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_fullStr Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_full_unstemmed Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_short Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_sort neuronal pre and postconditioning via toll like receptor 3 agonist or extracorporeal shock wave therapy as new treatment strategies for spinal cord ischemia an in vitro study
topic thoracoabdominal aneurysm
spinal cord ischemia
ischemic conditioning
Toll-like receptor 3
shock wave therapy
url https://www.mdpi.com/2077-0383/11/8/2115
work_keys_str_mv AT danielalobenwein neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT rosaliehuber neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT larskerbler neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT alexandragratl neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT sabinewipper neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT cangollmanntepekoylu neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT johannesholfeld neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy